bekhterevОбозрение психиатрии и медицинской психологии имени В.М.БехтереваV.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY2313-70532713-055XV. M. BEKHTEREV NATIONAL RESEARCH MEDICAL CENTER FOR PSYCHIATRY AND NEUROLOGY OF THE RUSSIAN FEDERATION MINISTRY OF HEALTH10.31363/2313-7053-2019-4-2-19-28bekhterev-338Research ArticleНАУЧНЫЕ ОБЗОРЫSCIENTIFIC REVIEWСопутствующие психические расстройства и нарушение эмоциональной регуляции у пациентов с рассеянным склерозомAssociated Psychological Disorders and Impairment of Emotional Regulation among Patients with Multiple SclerosisАндрееваМ. Т.AndreevaM. T.

Андреева Мария Трофимовна — врач — невролог Санкт-Петербургского городского центра рассеянного склероза и других аутоиммунный заболеваний (СПбГБУЗ ГКБ№31); аспирант кафедры медицинской психологии и психофизиологии СПбГУ.

Санкт-Петербург.

ascella777@gmail.comКараваеваТ. А.KaravaevaT. A.

Караваева  Татьяна  Артуровна — доктор  медицинских  наук,  главный  научный  сотрудник,  руководитель  отделения  лечения  пограничных  психических  расстройств  и  психотерапии  НМИЦ ПН им. В.М. Бехтерева;  профессор  кафедры  медицинской  психологии  и  психофизиологии  СПбГУ.

Санкт-Петербург.

tania_kar@mail.ruСанкт-Петербургский городской центр рассеянного склероза и других аутоиммунный заболеваний; Санкт-Петербургский государственный университетРоссияSt. Petersburg City Center for Multiple Sclerosis and Other Autoimmune Diseases; Saint-Petersburg State UniversityRussian FederationНациональный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева Минздрава России; Санкт-Петербургский государственный университетРоссияV. M. Bekhterev National Research Medical Center for Psychiatry and Neurology; Saint-Petersburg State UniversityRussian Federation20190201202004-21928Copyright © Андреева М.Т., Караваева Т.А., 20202020Андреева М.Т., Караваева Т.А.Andreeva M.T., Karavaeva T.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.bekhterevreview.com/jour/article/view/338

В обзоре литературных данных приведены результаты изучения коморбидных психических расстройств при рассеянном склерозе, освещены научные публикации отечественных и зарубежных исследований. Большая распространенность аффективных и адаптационных нарушений связана как с нейрофизиологическими особенностями протекания этого хронического прогредиентного нейродегенеративного заболевания, так и с психологическими факторами — индивидуальными личностными особенностями, отношением к заболеванию, изменению социального функционирования,  прогнозу. Показано, что у пациентов  с рассеянным склерозом частота развития  депрессивных, тревожных нарушений, посттравматического стрессового расстройства существенно выше, чем в общей популяции, что определяет необходимость комплексного персонализированного подхода к этой группе больных.

The review of data  from  the  available literature  cites the  results of studies of psychological disorders  comorbid  to  multiple  sclerosis and  highlights  scientific papers  detailing  domestic  and  foreign research. The high prevalence of affective and adaptive impairment  is linked both to the neurophysiological particularities of this chronic, progressive, neurodegenerative illness and to psychological factors — individual personality traits and the attitude of those afflicted to their illness, to the change in their social functioning and  to  their  prognosis. It  is demonstrated  that  patients  with multiple  sclerosis have a significantly higher frequency of depressive and anxiety disorders than  the general population,  which suggests the need for an integrated, personalized approach to people with this illness.

рассеянный склерозкоморбидные психические расстройствабиполярное расстройстводепрессиятревожные расстройствапосттравматическое стрессовое расстройствоmultiple sclerosiscomorbid psychological disordersbipolar disorderdepressionanxiety disordersposttraumatic stress disorderReferencesБойко О.В., Татаринова М.Ю., Попова Е.В., Гусева М.Р., Бойко А.Н., Гусев Е.И. Улучшение показателей качества жизни больных рассеянным склерозом за 15-летний период. Журнал неврологии и психиатрии им С.С. Корсакова. 2018; 2:23-28. doi.org/10.17116/jnevro201811808223Boyko O.V., Tatarinova M.YU., Popova E.V., Guseva M.R., Boyko A.N., Gusev E.I. The improvement of quality of life of patients with multiple sclerosis over 15-year period. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018; 2:23-28 (In Russ.). doi.org/10.17116/jnevro201811808223Васильева А.В., Караваева Т.А., Лукошкина Е.П., Карпов А.В. Социально-психологические факторы риска развития посттравматического стрессового расстройства у пациентов с онкологическими заболеваниями прямой кишки, подвергшихся хирургическому лечению с формированием колостомы. Обозрение психиатрии и медицинской психологии им. В.М. Бехтерева. 2018; 2:44-53.Vasileva A.V., Karavaeva T.A., Lukoshkina E.P., Karpov A.V. Socio-psychological risk factors for the development of posttraumatic stress disorder in patients with rectum cancer, who undergone colostomia. Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva. 2018; 2:44-53 (In Russ.).Каплин А., Кэролл К. Рассеянный склероз. В кн.: К. Ликетос , Питер В. Рэбинс, Джон Р. Липси, Филлип Р. Слэвни. Психиатрические аспекты неврологических заболеваний: Подходы к ведению больных. Пер. с англ. Под ред. Акад. РАН Н.Н. Яхно. — М.: МЕДпресс — информ. 2017:116¬136.Kaplin A., Carroll K., Rasseyannyi skleroz. V kn.: C. Lyketsos, P. Rabins, J. Lipsey, P. Slavney. Psychiatric aspects of neurologic diseases. Practical approaches to patient care. MEDpress — inform. 2017:116-136. (In Russ.).Карвасарский Б.Д. Клиническая психология: учебник для вузов. 5-е изд. СПб.: Питер. 2016; 896.Karvasarskii B.D. Klinicheskaya psikhologiya: uchebnik dlya vuzov. 5-e izd. SPb.: Piter. 2016; 896 (In Russ.).Лурия А.Р. Высшие корковые функции человека. — СПб.: Питер. 2019; 768:47-104.Luriya A.R. Vysshie korkovye funktsii cheloveka. — SPb.: Piter. 2019;768:47-104 (In Russ.).Мартынихин И.А. Эпидемиология, особенности и специфические факторы риска расстройств депрессивного спектра у женщин. Женское психическое здоровье — от истерии к гендерно-сенситивному подходу. Под общей редакцией: Н.Г. Незнанова. Авторы-составители: А.В. Васильева, Т.А. Караваева. Санкт-Петербург: Издательский Дом «Алеф-Пресс». 2018; 208-222.Martynikhin I.A. Epidemiologiya, osobennosti i spetsificheskie faktory riska rasstroistv depressivnogo spektra u zhenshchin. Zhenskoe psikhicheskoe zdorove — ot isterii k genderno-sensitivnomu podkhodu. Pod obshchei redaktsiei: N. G. Neznanova. Avtory-sostaviteli: A.V. Vasileva, T.A. Karavaeva. Sankt-Peterburg: Izdatel’skii Dom «Alef-Press». 2018; 208-222 (In Russ.).Николаев Е.Л., Караваева Т.А., Васильева Н.В., Чехлатый Е.И. Персонализированный подход в медико-психологическом сопровождении больных с рассеянным склерозом. Вестник пси-хотерапии. 2018; 65(70) 86-97.Nikolaev E.L., Karavaeva T.A., Vasileva N.V., Chekhlatyi E.I. The personalized approach in medical and psychological support of multiple sclerosis patients. Vestnik psikhoterapii. 2018; 65(70) 86-97 (In Russ.).Николаев Е.Л., Караваева Т.А., Васильева Н.В. Медико-психологическое сопровождение больных с рассеянным склерозом: основные принципы и задачи. Обозрение психиатрии и медицинской психологии им. В.М. Бехтерева. 2018; 1:120-124.Nikolaev E.L., Karavaeva T.A., Vasileva N.V. Medical and psychological support of multiple sclerosis patients: basic principles and objectives. Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva. 2018; 1:120-124 (In Russ.).Сирота Н.А., Московченко Д.В., Ялтонский В.М., Ялтонская А.В. Беспокойство о прогрессировании онкологического заболевания: современные теоретические концепции и подходы. Медицинская психология в России: электрон. науч. журн. 2016; 6:41 URL: http://mprj.ru (дата обращения: 30.04.2018).Sirota N.A., Moskovchenko D.V., Yaltonskii V.M., Yaltonskaya A.V Аnxiety on the progression of oncological diseases: modern theoretical concepts and approaches. Meditsinskaya psikhologiya v Rossii: elektron. nauch. zhurn. 2016; 6:41 (data obrashenia: 30.04.2018 (In Russ.).Хомская Е.Д. Нейропсихология: учебник для вузов. 4-е изд. — СПб.: Питер. 2018; 496.Khomskaya E.D. Neiropsikhologiya: uchebnik dlya vuzov. 4-e izd. — SPb.: Piter. 2018; 496 (In Russ.).Шмидт Т.Е., Яхно Н.Н. Рассеянный склероз: руководство для врачей. 3-е изд. — М.: МЕД-пресс — информ. 2012; 272:13-64.Shmidt T.E., Yakhno N.N. Rasseyannyi skleroz: rukovodstvo dlya vrachei. 3-e izd. — M.: MEDpress — inform. 2012; 272:13 — 64 (In Russ.).Anderson D, Ellenberg J, Leventhal C, Reingold S, Rodriguez M, Silberberg D. Revised estimate of the prevalence of multiple sclerosis in the united states. Ann Neurol. 1992; 31(3):333-336. doi:10.1002/ana.410310317Anderson D, Ellenberg J, Leventhal C, Reingold S, Rodriguez M, Silberberg D. Revised estimate of the prevalence of multiple sclerosis in the united states. Ann Neurol. 1992; 31(3):333-336. doi:10.1002/ana.410310317Aronson K, Cleghorn G, Goldenberg E. Assistance arrangements and use of services among persons with multiple sclerosis and their care-givers. Disabil Rehabil. 1996; 18(7):354-361. doi:10.3109/09638289609165894Aronson K, Cleghorn G, Goldenberg E. Assistance arrangements and use of services among persons with multiple sclerosis and their care-givers. Disabil Rehabil. 1996; 18(7):354-361. doi:10.3109/09638289609165894Association between bipolar affective disorder and multiple sclerosis. American Journal of Psychiatry. 1986; 143(1):94-95. doi:10.1176/ajp.143.1.94Association between bipolar affective disorder and multiple sclerosis. American Journal of Psychiatry. 1986; 143(1):94-95. doi:10.1176/ajp.143.1.94Bakshi R, Czarnecki D, Shaikh Z et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport. 2000; 11(6):1153-1158. doi:10.1097/00001756-200004270-00003Bakshi R, Czarnecki D, Shaikh Z et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport. 2000; 11(6):1153-1158. doi:10.1097/00001756-200004270-00003Barak Y, Achiron A, Elizur A, Gabbay U, Noy S, Sarova-Pinhas I. Sexual dysfunction in relapsing-remitting multiple aclerosis: Clinical, psychological and MRI correlates. J Neuroimmunol. 1995; 56-63:56-56. doi:10.1016/0165-5728(95)99052-kBarak Y, Achiron A, Elizur A, Gabbay U, Noy S, Sarova-Pinhas I. Sexual dysfunction in relapsing-remitting multiple aclerosis: Clinical, psychological and MRI correlates. J Neuroimmunol. 1995; 56-63:56-56. doi:10.1016/0165-5728(95)99052-kBenedict R, Carone D, Bakshi R. Correlating Brain Atrophy With Cognitive Dysfunction, Mood Disturbances, and Personality Disorder in Multiple Sclerosis. Journal of Neuroimaging. 2004; 14:36S-45S. doi:10.1111/j.1552-6569.2004.tb00277.xBenedict R, Carone D, Bakshi R. Correlating Brain Atrophy With Cognitive Dysfunction, Mood Disturbances, and Personality Disorder in Multiple Sclerosis. Journal of Neuroimaging. 2004; 14:36S-45S. doi:10.1111/j.1552-6569.2004.tb00277.xBoeschoten R, Braamse A, Beekman A et al. Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. J Neurol Sci. 2017; 372:331-341. doi:10.1016/j.jns.2016.11.067Boeschoten R, Braamse A, Beekman A et al. Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. J Neurol Sci. 2017; 372:331-341. doi:10.1016/j.jns.2016.11.067Brown S. The mental symptoms of multiple sclerosis. Arch Neurol Psychiatry 1922; 7(5):629.Brown S. The mental symptoms of multiple sclerosis. Arch Neurol Psychiatry 1922; 7(5):629.doi:10.1001/archneurpsyc.1922.02190110080008doi:10.1001/archneurpsyc.1922.02190110080008Butler E, Matcham F, Chalder T. A systematic review of anxiety amongst people with Multiple Sclerosis. Mult Scler Relat Disord. 2016; 10:145-168. doi:10.1016/j.msard.2016.10.003Butler E, Matcham F, Chalder T. A systematic review of anxiety amongst people with Multiple Sclerosis. Mult Scler Relat Disord. 2016; 10:145-168. doi:10.1016/j.msard.2016.10.003Chahraoui K, Pinoit J, Viegas N, Adnet J, Bonin B, Moreau T. Alexithymie et liens avec la depression et lanxiete dans la sclerose en plaques. Rev Neu¬rol (Paris). 2008; 164(3):242-245. doi:10.1016/j.neurol.2007.09.006Chahraoui K, Pinoit J, Viegas N, Adnet J, Bonin B, Moreau T. Alexithymie et liens avec la depression et lanxiete dans la sclerose en plaques. Rev Neu¬rol (Paris). 2008; 164(3):242-245. doi:10.1016/j.neurol.2007.09.006Chalah M, Ayache S. Psychiatric event in multiple sclerosis: could it be the tip of the iceberg?. Revista Brasileira de Psiquiatria. 2017; 39(4):365-368. doi:10.1590/1516-4446-2016-2105Chalah M, Ayache S. Psychiatric event in multiple sclerosis: could it be the tip of the iceberg?. Revista Brasileira de Psiquiatria. 2017; 39(4):365-368. doi:10.1590/1516-4446-2016-2105Chalfant A, Bryant R, Fulcher G. Posttraumatic stress disorder following diagnosis of multiple sclerosis. J Trauma Stress. 2004; 17(5):423-428. doi:10.1023/b:jots.0000048955.65891.4cChalfant A, Bryant R, Fulcher G. Posttraumatic stress disorder following diagnosis of multiple sclerosis. J Trauma Stress. 2004; 17(5):423-428. doi:10.1023/b:jots.0000048955.65891.4cCharcot J, Seigerson G. “Lectures 6 through 8,” in Lectures on the Diseases of the Nervous System. Delivered at La Salpetriere. Am J Med Sci. 1877; 148(4):532-533. doi:10.1097/00000441-187710000-00035Charcot J, Seigerson G. “Lectures 6 through 8,” in Lectures on the Diseases of the Nervous System. Delivered at La Salpetriere. Am J Med Sci. 1877; 148(4):532-533. doi:10.1097/00000441-187710000-00035Cottrell S, Wilson S. Original Papers: The affective symptomatology of disseminated sclerosis: a study of 100 cases. Journal of Neurology, Neurosurgery & Psychiatry. 1926; s1-7(25):1-30. doi:10.1136/jnnp.s1-7.25.1Cottrell S, Wilson S. Original Papers: The affective symptomatology of disseminated sclerosis: a study of 100 cases. Journal of Neurology, Neurosurgery & Psychiatry. 1926; s1-7(25):1-30. doi:10.1136/jnnp.s1-7.25.1Dantzer R. Cytokine-Induced Sickness Behavior: Where Do We Stand? Brain Behav Immun. 2001; 15(1):7-24. doi:10.1006/brbi.2000.0613Dantzer R. Cytokine-Induced Sickness Behavior: Where Do We Stand? Brain Behav Immun. 2001; 15(1):7-24. doi:10.1006/brbi.2000.0613Diaz-Olavarrieta C, Cummings J, Velazquez J, Garcia de al Cadena C. Neuropsychiatric Mani-festations of Multiple Sclerosis. J Neuropsychiatry Clin Neurosci. 1999; 11(1):51-57. doi:10.1176/jnp.11.1.51Diaz-Olavarrieta C, Cummings J, Velazquez J, Garcia de al Cadena C. Neuropsychiatric Mani-festations of Multiple Sclerosis. J Neuropsychiatry Clin Neurosci. 1999; 11(1):51-57. doi:10.1176/jnp.11.1.51Duncan A, Malcolm-Smith S, Ameen O, Solms M. Changing definitions of euphoria in multiple sclerosis: A short report. Multiple Sclerosis Journal. 2014; 21(6):776-779. doi:10.1177/1352458514549400Duncan A, Malcolm-Smith S, Ameen O, Solms M. Changing definitions of euphoria in multiple sclerosis: A short report. Multiple Sclerosis Journal. 2014; 21(6):776-779. doi:10.1177/1352458514549400Duncan A, Malcolm-Smith S, Ameen O, Solms M. The Incidence of Euphoria in Multiple Sclerosis: Artefact of Measure. Mult Scler Int. 20116 2016:1-8. doi:10.1155/2016/5738425Duncan A, Malcolm-Smith S, Ameen O, Solms M. The Incidence of Euphoria in Multiple Sclerosis: Artefact of Measure. Mult Scler Int. 20116 2016:1-8. doi:10.1155/2016/5738425Feinstein A, Magalhaes S, Richard J, Audet B, Moore C. The link between multiple sclerosis and depression. Nature Reviews Neurology. 2014; 10(9):507-517. doi:10.1038/nrneurol.2014.139Feinstein A, Magalhaes S, Richard J, Audet B, Moore C. The link between multiple sclerosis and depression. Nature Reviews Neurology. 2014; 10(9):507-517. doi:10.1038/nrneurol.2014.139Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology. 2002; 59(5):674-678. doi:10.1212/wnl.59.5.674Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology. 2002; 59(5):674-678. doi:10.1212/wnl.59.5.674Feinstein A. The Neuropsychiatry of Multiple Sclerosis. The Canadian Journal of Psychiatry. 2004; 49(3):157-163. doi:10.1177/070674370404900302Feinstein A. The Neuropsychiatry of Multiple Sclerosis. The Canadian Journal of Psychiatry. 2004; 49(3):157-163. doi:10.1177/070674370404900302Figved N, Klevan G, Myhr K et al. Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psychiatr Scand. 2005; 112(6):463-468. doi:10.1111/j.1600-0447.2005.00624.xFigved N, Klevan G, Myhr K et al. Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psychiatr Scand. 2005; 112(6):463-468. doi:10.1111/j.1600-0447.2005.00624.xFilippi M, Alberoni M, Martinelli V et al. Influence of Clinical Variables on Neuropsychological Performance in Multiple Sclerosis. Eur Neurol. 1994; 34(6):324-328. doi:10.1159/000117071Filippi M, Alberoni M, Martinelli V et al. Influence of Clinical Variables on Neuropsychological Performance in Multiple Sclerosis. Eur Neurol. 1994; 34(6):324-328. doi:10.1159/000117071Fishman I, Benedict R, Bakshi R, Priore R, Weinstock-Guttman B. Construct Validity and Frequency of Euphoria Sclerotica in Multiple Sclerosis. J Neuropsychiatry Clin Neurosci. 2004; 16(3):350-356. doi:10.1176/jnp.16.3.350Fishman I, Benedict R, Bakshi R, Priore R, Weinstock-Guttman B. Construct Validity and Frequency of Euphoria Sclerotica in Multiple Sclerosis. J Neuropsychiatry Clin Neurosci. 2004; 16(3):350-356. doi:10.1176/jnp.16.3.350Fisk J, Pontefract A, Ritvo P, Archibald C, Murray T. The Impact of Fatigue on Patients with Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 1994; 21(01):9-14. doi:10.1017/s0317167100048691Fisk J, Pontefract A, Ritvo P, Archibald C, Murray T. The Impact of Fatigue on Patients with Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 1994; 21(01):9-14. doi:10.1017/s0317167100048691Gay M, Bungener C, Thomas S et al. Anxiety, emotional processing and depression in people with multiple sclerosis. BMC Neurol. 2017; 17(1). doi:10.1186/s12883-017-0803-8Gay M, Bungener C, Thomas S et al. Anxiety, emotional processing and depression in people with multiple sclerosis. BMC Neurol. 2017; 17(1). doi:10.1186/s12883-017-0803-8Gay M, Vrignaud P, Garitte C, Meunier C. Predictors of depression in multiple sclerosis patients. Acta Neurol Scand. 2010; 121(3):161-170. doi:10.1111/j.1600-0404.2009.01232.xGay M, Vrignaud P, Garitte C, Meunier C. Predictors of depression in multiple sclerosis patients. Acta Neurol Scand. 2010; 121(3):161-170. doi:10.1111/j.1600-0404.2009.01232.xGeorge M, Kellner C, Bernstein H, Goust J. A Magnetic Resonance Imaging Investigation into Mood Disorders in Multiple Sclerosis. J Nerv Ment Dis. 1994; 182(7)408-411. doi:10.1097/00005053-199407000-00008George M, Kellner C, Bernstein H, Goust J. A Magnetic Resonance Imaging Investigation into Mood Disorders in Multiple Sclerosis. J Nerv Ment Dis. 1994; 182(7)408-411. doi:10.1097/00005053-199407000-00008Gerolimatos LA, Edelstein BA. Predictors of health anxiety among older and young adults. International Psychogeriatrics. 2012; 24(12):1998-2008. doi: http://dx.doi.org/10.1017/S1041610212001329.Gerolimatos LA, Edelstein BA. Predictors of health anxiety among older and young adults. International Psychogeriatrics. 2012; 24(12):1998-2008. doi: http://dx.doi.org/10.1017/S1041610212001329.Goodin D. The epidemiology of multiple sclero¬sis. Neuroepidemiology. 206:; 173-206. doi:10.1016/b978-0-12-802973-2.00011-2Goodin D. The epidemiology of multiple sclero¬sis. Neuroepidemiology. 206:; 173-206. doi:10.1016/b978-0-12-802973-2.00011-2Haussleiter I, Brune M, Juckel G. Review: Psycho-pathology in multiple sclerosis: diagnosis, preva-lence and treatment. Ther Adv Neurol Disord. 2009; 2(1):13-29. doi:10.1177/1756285608100325Haussleiter I, Brune M, Juckel G. Review: Psycho-pathology in multiple sclerosis: diagnosis, preva-lence and treatment. Ther Adv Neurol Disord. 2009; 2(1):13-29. doi:10.1177/1756285608100325Hemmer B, Kerschensteiner M, Korn T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. The Lancet Neurology. 2015; 14(4):406-419. doi:10.1016/s1474-4422(14)70305-9Hemmer B, Kerschensteiner M, Korn T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. The Lancet Neurology. 2015; 14(4):406-419. doi:10.1016/s1474-4422(14)70305-9Henry A, Tourbah A, Camus G et al. Anxiety and depression in patients with multiple sclero¬sis: The mediating effects of perceived social support. Mult Scler Relat Disord. 2019; 27:46-51. doi:10.1016/j.msard.2018.09.03925.Henry A, Tourbah A, Camus G et al. Anxiety and depression in patients with multiple sclero¬sis: The mediating effects of perceived social support. Mult Scler Relat Disord. 2019; 27:46-51. doi:10.1016/j.msard.2018.09.03925.Haussleiter I, Brune M, Juckel G. Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment. Ther Adv Neurol Disord. 2009; 2(1):13-29. doi:10.1177/1756285608100325Haussleiter I, Brune M, Juckel G. Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment. Ther Adv Neurol Disord. 2009; 2(1):13-29. doi:10.1177/1756285608100325Interferon beta-lb in the treatment of multiple sclerosis: Final outcome of the randomized con-trolled trial. Neurology. 1995; 45(7):1277-1285. doi:10.1212/wnl.45.7.1277Interferon beta-lb in the treatment of multiple sclerosis: Final outcome of the randomized con-trolled trial. Neurology. 1995; 45(7):1277-1285. doi:10.1212/wnl.45.7.1277Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW, and the CHAMPS Study Group. N Engl J Med. 2000; 343:898-904. Am J Ophthalmol. 2001; 131(1):154-155. doi:10.1016/s0002-9394(00)00915-6Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW, and the CHAMPS Study Group. N Engl J Med. 2000; 343:898-904. Am J Ophthalmol. 2001; 131(1):154-155. doi:10.1016/s0002-9394(00)00915-6Johnson K, Brooks B, Cohen J et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-con-trolled trial. Neurology. 1995; 45(7):1268-1276. doi:10.1212/wnl.45.7.1268Johnson K, Brooks B, Cohen J et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-con-trolled trial. Neurology. 1995; 45(7):1268-1276. doi:10.1212/wnl.45.7.1268Jopson N, Moss-Morris R. The role of illness severity and illness representations in adjusting to multiple sclerosis. J Psychosom Res. 2003; 54(6):503-511. doi:10.1016/s0022-3999(02)00455-Klapper J. Interferon beta treatment of multiple sclerosis. Neurology. 1994; 44(1):188-188. doi:10.1212/wnl.44.1.188-aJopson N, Moss-Morris R. The role of illness severity and illness representations in adjusting to multiple sclerosis. J Psychosom Res. 2003; 54(6):503-511. doi:10.1016/s0022-3999(02)00455-Klapper J. Interferon beta treatment of multiple sclerosis. Neurology. 1994; 44(1):188-188. doi:10.1212/wnl.44.1.188-aKubzansky LD, Thurston RC. Emotional vitality and incident coronary heart disease: Benefits of healthy psychological functioning. Archives of General Psychiatry. 2007; 64(12):1393-1401. doi: http://dx.doi.org/10.1001/archpsyc.64.12.1393Kubzansky LD, Thurston RC. Emotional vitality and incident coronary heart disease: Benefits of healthy psychological functioning. Archives of General Psychiatry. 2007; 64(12):1393-1401. doi: http://dx.doi.org/10.1001/archpsyc.64.12.1393Lee B, Dantzer R, Langley K et al. A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related Symptoms. Neuroimmunomodulation. 2004; 11(5):279-292. doi:10.1159/000079408Lee B, Dantzer R, Langley K et al. A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related Symptoms. Neuroimmunomodulation. 2004; 11(5):279-292. doi:10.1159/000079408Lublin F, Reingold S, Cohen J et al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology. 2014; 83(3):278-286. doi:10.1212/wnl.0000000000000560Lublin F, Reingold S, Cohen J et al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology. 2014; 83(3):278-286. doi:10.1212/wnl.0000000000000560Lynch S, Kroencke D, Denney D. The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope. Multiple Sclerosis. 2001; 7(6):411-416. doi:10.1191/135245801701566998Lynch S, Kroencke D, Denney D. The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope. Multiple Sclerosis. 2001; 7(6):411-416. doi:10.1191/135245801701566998Malik U, Makower D, Wadler S. Interferon-mediated fatigue. Cancer. 2001; 92(S6):1664-1668. doi:10.1002/1097-0142(20010915)92:6+<1664::aid-cncr1494>3.0.co;2-9Malik U, Makower D, Wadler S. Interferon-mediated fatigue. Cancer. 2001; 92(S6):1664-1668. doi:10.1002/1097-0142(20010915)92:6+<1664::aid-cncr1494>3.0.co;2-9Minden S. Mood disorders in multiple sclerosis: diagnosis and treatment. Journal of Neurovirology. 2000; 6(2):160-167.Minden S. Mood disorders in multiple sclerosis: diagnosis and treatment. Journal of Neurovirology. 2000; 6(2):160-167.Minden S, Schiffer R. Affective Disorders in Multiple Sclerosis Review and Recommendations for Clinical Research. Arch Neurol. 1990; 47(1):98-104. doi:10.1001/archneur.1990.00530010124031Minden S, Schiffer R. Affective Disorders in Multiple Sclerosis Review and Recommendations for Clinical Research. Arch Neurol. 1990; 47(1):98-104. doi:10.1001/archneur.1990.00530010124031Minden S, Orav J, Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry. 1987; 9(6):426-434. doi:10.1016/0163-8343(87)90052-1Minden S, Orav J, Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry. 1987; 9(6):426-434. doi:10.1016/0163-8343(87)90052-1Mohr D, Hart S, Goldberg A. Effects of Treatment for Depression on Fatigue in Multiple Sclerosis. Psychosom Med. 2003; 65(4):542-547. doi:10.1097/01.psy.0000074757.11682.96Mohr D, Hart S, Goldberg A. Effects of Treatment for Depression on Fatigue in Multiple Sclerosis. Psychosom Med. 2003; 65(4):542-547. doi:10.1097/01.psy.0000074757.11682.96Moller A, Wiedemann G, Rohde U, Backmund H, Sonntag A. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand. 1994; 89(2):117-121. doi:10.1111/j.1600-0447.1994.tb01497.xMoller A, Wiedemann G, Rohde U, Backmund H, Sonntag A. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand. 1994; 89(2):117-121. doi:10.1111/j.1600-0447.1994.tb01497.xMoriya R, Kutsumi M. Fatigue in Japanese people with multiple sclerosis. Nurs Health Sci. 2010; 12(4):421-428. doi:10.1111/j.1442-2018.2010.00554.xMoriya R, Kutsumi M. Fatigue in Japanese people with multiple sclerosis. Nurs Health Sci. 2010; 12(4):421-428. doi:10.1111/j.1442-2018.2010.00554.xNoy S, Achiron A, Gabbay U et al. A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry. 1995; 36(5):390-395. doi:10.1016/s0010-440x(95)90121-3Noy S, Achiron A, Gabbay U et al. A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry. 1995; 36(5):390-395. doi:10.1016/s0010-440x(95)90121-3Ostacoli L, Carletto S, Borghi M et al. Prevalence and Significant Determinants of Post-traumatic Stress Disorder in a Large Sample of Patients with Multiple Sclerosis. J Clin Psychol Med Settings. 2012; 20(2):240-246. doi:10.1007/s10880-012-9323-239.Ostacoli L, Carletto S, Borghi M et al. Prevalence and Significant Determinants of Post-traumatic Stress Disorder in a Large Sample of Patients with Multiple Sclerosis. J Clin Psychol Med Settings. 2012; 20(2):240-246. doi:10.1007/s10880-012-9323-239.Panda S, Das R, Srivastava K, Ratnam A, Sharma N. Psychiatric comorbidity in multiple sclerosis. Neurol Neurochir Pol. 2018; 52(6):704-709. doi:10.1016/j.pjnns.2018.09.003Panda S, Das R, Srivastava K, Ratnam A, Sharma N. Psychiatric comorbidity in multiple sclerosis. Neurol Neurochir Pol. 2018; 52(6):704-709. doi:10.1016/j.pjnns.2018.09.003Patten S, Marrie R, Carta M. Depression in multiple sclerosis. International Review of Psychiatry. 2017; 29(5):463-472. doi:10.1080/09540261.2017.1 322555Patten S, Marrie R, Carta M. Depression in multiple sclerosis. International Review of Psychiatry. 2017; 29(5):463-472. doi:10.1080/09540261.2017.1 322555Patten S, Metz L. Interferon 1a and depression in secondary progressive MS: Data from the SPEC-TRIMS Trial. Neurology. 2002; 59(5):744-746. doi:10.1212/wnl.59.5.744Patten S, Metz L. Interferon 1a and depression in secondary progressive MS: Data from the SPEC-TRIMS Trial. Neurology. 2002; 59(5):744-746. doi:10.1212/wnl.59.5.744Patten S, Metz L. Interferon fi-1a and depression in relapsing — remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial. Multiple Sclerosis Journal. 2001; 7(4):243-248. doi:10.1177/135245850100700406Patten S, Metz L. Interferon fi-1a and depression in relapsing — remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial. Multiple Sclerosis Journal. 2001; 7(4):243-248. doi:10.1177/135245850100700406Patten S, Metz L, Reimer M. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Multiple Sclerosis. 2000; 6(2):115-120. doi:10.1191/135245800678827536Patten S, Metz L, Reimer M. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Multiple Sclerosis. 2000; 6(2):115-120. doi:10.1191/135245800678827536Pujol J, Bello J, Deus J, Marti-Vilalta J, Capdevila A. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology. 1997; 49(4):1105-1110. doi:10.1212/wnl.49.4.1105Pujol J, Bello J, Deus J, Marti-Vilalta J, Capdevila A. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology. 1997; 49(4):1105-1110. doi:10.1212/wnl.49.4.1105Rabins P, Brooks B, O’Donnell P et al. Structural brain correlates of emotional disorder in multiple sclerisis. Brain. 1986; 109(4):585-597. doi:10.1093/brain/109.4.585Rabins P, Brooks B, O’Donnell P et al. Structural brain correlates of emotional disorder in multiple sclerisis. Brain. 1986; 109(4):585-597. doi:10.1093/brain/109.4.585Rabkin J, Albert S, Del Bene M et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology. 2005; 65(1):62-67. doi:10.1212/01.wnl.0000167187.14501.0cRabkin J, Albert S, Del Bene M et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology. 2005; 65(1):62-67. doi:10.1212/01.wnl.0000167187.14501.0cRaison C, Demetrashvili M, Capuron L, Miller A. Neuropsychiatric Adverse Effects of Interferon-alpha. CNS Drugs. 2005; 19(2):105-123. doi:10.2165/00023210-200519020-00002Raison C, Demetrashvili M, Capuron L, Miller A. Neuropsychiatric Adverse Effects of Interferon-alpha. CNS Drugs. 2005; 19(2):105-123. doi:10.2165/00023210-200519020-00002Reischies F. Cerebral Magnetic Resonance Imaging Findings in Multiple Sclerosis. Arch Neurol. 1988; 45(10):1114. doi:10.1001/archneur.1988.00520340068014Reischies F. Cerebral Magnetic Resonance Imaging Findings in Multiple Sclerosis. Arch Neurol. 1988; 45(10):1114. doi:10.1001/archneur.1988.00520340068014Sabatini U, Pozzilli C, Pantano P et al. Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol Psychiatry. 1996; 39(11):970-975. doi:10.1016/0006-3223(95)00291-%Sabatini U, Pozzilli C, Pantano P et al. Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol Psychiatry. 1996; 39(11):970-975. doi:10.1016/0006-3223(95)00291-%Sadovnick A, Eisen K, Ebers G, Paty D. Cause of death in patients attending multiple sclerosis clinics. Neurology. 1991; 41(8):1193-1193. doi:10.1212/wnl.41.8.1193Sadovnick A, Eisen K, Ebers G, Paty D. Cause of death in patients attending multiple sclerosis clinics. Neurology. 1991; 41(8):1193-1193. doi:10.1212/wnl.41.8.1193Sai-Halasz A. Psychic Alterations in Disseminated Sclerosis A General, Statistical and Rorschach-Test Study on 200 Patients. Eur Neurol. 1956; 132(2-3):129-154. doi:10.1159/000139628Sai-Halasz A. Psychic Alterations in Disseminated Sclerosis A General, Statistical and Rorschach-Test Study on 200 Patients. Eur Neurol. 1956; 132(2-3):129-154. doi:10.1159/000139628Sanfilipo M, Benedict R, Weinstock-Guttman B, Bakshi R. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology. 2006; 66(5):685-692. doi:10.1212/01.wnl.0000201238.93586.d9Sanfilipo M, Benedict R, Weinstock-Guttman B, Bakshi R. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology. 2006; 66(5):685-692. doi:10.1212/01.wnl.0000201238.93586.d9Schaefer M, Engelbrechta M, Gut O et al. Interferon alpha (IFNa) and psychiatric syndromes. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2002; 26(4):731-746. doi:10.1016/s0278-5846(01)00324-4Schaefer M, Engelbrechta M, Gut O et al. Interferon alpha (IFNa) and psychiatric syndromes. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2002; 26(4):731-746. doi:10.1016/s0278-5846(01)00324-4Schiffer R. Multiple Sclerosis and Affective Disorder. Arch Neurol. 1988;45(12):1345. doi:10.1001/ archneur.1988.00520360063013Schiffer R. Multiple Sclerosis and Affective Disorder. Arch Neurol. 1988;45(12):1345. doi:10.1001/ archneur.1988.00520360063013Siegert R. Depression in multiple sclerosis: a review. Journal of Neurology, Neurosurgery & Psychiatry. 2005; 76(4):469-475. doi:10.1136/jnnp.2004.054635Siegert R. Depression in multiple sclerosis: a review. Journal of Neurology, Neurosurgery & Psychiatry. 2005; 76(4):469-475. doi:10.1136/jnnp.2004.054635Sugar C, Nadell R. Mental symptoms in multiple sclerosis. J Nerv Ment Dis. 1943; 98(3):267-280. doi:10.1097/00005053-194309000-00004Sugar C, Nadell R. Mental symptoms in multiple sclerosis. J Nerv Ment Dis. 1943; 98(3):267-280. doi:10.1097/00005053-194309000-00004Tedman B, Young C, Williams I. Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. J Neurol Sci. 1997; 152s75s79. doi:10.1016/s0022-510x(97)00249-9Tedman B, Young C, Williams I. Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. J Neurol Sci. 1997; 152s75s79. doi:10.1016/s0022-510x(97)00249-9Trask P, Paterson A, Esper P, Pau J, Redman B. Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon. Psychooncology. 2004; 13(8)526-536. doi:10.1002/pon.770Trask P, Paterson A, Esper P, Pau J, Redman B. Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon. Psychooncology. 2004; 13(8)526-536. doi:10.1002/pon.770Vercoulen J. The Measurement of Fatigue in Patients With Multiple Sclerosis. Arch Neurol. 1996; 53(7):642. doi:10.1001/arch-neur.1996.00550070080014Vercoulen J. The Measurement of Fatigue in Patients With Multiple Sclerosis. Arch Neurol. 1996; 53(7):642. doi:10.1001/arch-neur.1996.00550070080014Weinshenker B, Bass B, Rice G et al. The natural history of multiple sclerosi : a geographically based study. Brain. 1989; 112(1):133-146. doi:10.1093/brain/112.1.133Weinshenker B, Bass B, Rice G et al. The natural history of multiple sclerosi : a geographically based study. Brain. 1989; 112(1):133-146. doi:10.1093/brain/112.1.133Wierenga K, Lehto R, Given B. Emotion Regulation in Chronic Disease Populations: An Integrative Re-view. Res Theory Nurs Pract. 2017; 31(3):247-271. doi:10.1891/1541-6577.31.3.247Wierenga K, Lehto R, Given B. Emotion Regulation in Chronic Disease Populations: An Integrative Re-view. Res Theory Nurs Pract. 2017; 31(3):247-271. doi:10.1891/1541-6577.31.3.247Whitlock F, Siskind M. Depression as a major symptom of multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. 1980; 43(10):861-865. doi:10.1136/jnnp.43.10.861Whitlock F, Siskind M. Depression as a major symptom of multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. 1980; 43(10):861-865. doi:10.1136/jnnp.43.10.861Wood B, van der Mei I, Ponsonby A et al. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Multiple Sclerosis Journal. 2012; 19(2):217-224. doi:10.1177/1352458512450351Wood B, van der Mei I, Ponsonby A et al. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Multiple Sclerosis Journal. 2012; 19(2):217-224. doi:10.1177/1352458512450351Zephir H, De Seze J, Stojkovic T et al. Multiple sclerosis and depression: influence of interferon b therapy. Multiple Sclerosis Journal. 2003; 9(3):284-288. doi:10.1191/1352458503ms915oaaZephir H, De Seze J, Stojkovic T et al. Multiple sclerosis and depression: influence of interferon b therapy. Multiple Sclerosis Journal. 2003; 9(3):284-288. doi:10.1191/1352458503ms915oaa

The authors declare that there are no conflicts of interest present.